1. Home
  2. LUCD

LUCD

Lucid Diagnostics Inc.

Logo Lucid Diagnostics Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Founded: 2018 Country:
N/A
Employees: N/A City: NEW YORK
Market Cap: 36.2M IPO Year: 2021
Target Price: $3.17 AVG Volume (30 days): 163.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.26 EPS Growth: N/A
52 Week Low/High: $0.78 - $1.85 Next Earning Date: 01-01-0001
Revenue: $2,428,000 Revenue Growth: 544.03%
Revenue Growth (this year): 161.28% Revenue Growth (next year): 184.85%

Share on Social Networks: